U.S. Pharma Stock News

If you are wondering whether Moelis shares offer good value at today's price, it helps to step back and look at what the current market is implying about the business. The stock last closed at US$51.75, after a 7.8% decline over the past week, a 25.1% decline over the past month, and a 27.3% decline year to date, while still showing a 51.6% return over 3 years and 23.6% over 5 years. These recent moves have kept Moelis on investors' radars, with market commentary often linking advisory firms...

Immunic, Inc. recently secured a key European patent for its lead asset vidofludimus calcium, aligning protection with existing U.S. coverage and potentially extending exclusivity into the 2040s for chronic inflammatory and autoimmune indications. This expanded intellectual property protection materially underpins the company’s core therapeutic franchise by lengthening its runway to develop and, if approved, commercialize its main clinical asset. Against this backdrop, we’ll explore how the...

Precision BioSciences (DTIL) closed out FY 2025 with Q4 revenue of US$34.2 million and Basic EPS of US$1.01, alongside earnings from discontinued operations of US$0.9 million and net income excluding extra items of US$19.2 million. Over recent quarters, the company has seen revenue range from US$0.6 million in Q4 2024 to US$34.2 million in Q4 2025. Over the same period, quarterly Basic EPS has moved from a loss of US$2.22 in Q4 2024 to a profit of US$1.01 in Q4 2025. This sets up an earnings...

TIC Solutions (NYSE:TIC) has appointed Ben Heraud as its new CEO, succeeding long-serving leader Tal Pizzey. The company has also launched a $200 million share repurchase program. These changes were recently announced and have not been widely discussed in prior coverage. TIC Solutions is making these moves at a time when its share price is $7.25, with the stock showing a 40.3% decline over the past year and a 26.7% decline year to date. The new leadership and buyback plan arrive against...

EverCommerce (EVCM) has wrapped up FY 2025 with fourth quarter revenue of US$151.2 million and basic EPS of US$0.03, alongside net income from ongoing operations of US$5.7 million. This caps a trailing twelve month period with revenue of US$588.9 million and EPS of US$0.10. Over recent quarters the company has seen revenue range from US$142.3 million to US$151.2 million, with quarterly EPS between US$0.01 and US$0.03. Over the same period, trailing twelve month net income from ongoing...

If you are wondering whether Fiverr International's current share price reflects its true worth, you are not alone. This article will walk you through what the numbers are actually saying about value. The stock has seen sizeable declines recently, with a 7.7% fall over the last week, a 27.6% decline over the last month, a 46.8% drop year to date, and a 59.2% decline over the past year. This extends a 68.5% and 95.3% fall across the last 3 and 5 years respectively. Recent attention on Fiverr...

Butler National (BUKS) has reported Q3 2026 revenue of US$26.9 million and basic EPS of US$0.10, set against trailing twelve month revenue of US$91.9 million and EPS of US$0.30 that came with 44.1% earnings growth and a 21.4% net margin over the past year. The company has seen quarterly revenue move from US$21.2 million in Q3 2025 to US$26.9 million in Q3 2026 and basic EPS from US$0.05 to US$0.10 across the same periods, with trailing net income reaching US$19.7 million, which positions the...

In early March 2026, Tenaya Therapeutics reported a narrower full-year 2025 net loss of US$90.6 million and highlighted new preclinical data for TN-301 in Duchenne muscular dystrophy alongside a research collaboration with Alnylam Pharmaceuticals on up to 15 cardiovascular gene targets that could yield as much as US$1.13 billion in milestones. Together, these updates underscore how Tenaya is pairing emerging HDAC6 science in DMD and heart failure with a genetically guided partnership model...

Capricor Therapeutics (CAPR) has just posted its FY 2025 first half results with total revenue of US$0 million and a basic EPS loss of US$1.10, while trailing twelve month revenue sits at US$13.39 million with a basic EPS loss of US$1.66. Over recent periods, the company has reported revenue of US$8.88 million and US$13.39 million across the two halves of FY 2024, alongside basic EPS losses of US$0.66 and US$0.51. This provides context for how current margins remain under pressure. With...

Constellium (NYSE:CSTM) has announced a new share repurchase program of up to $300 million, authorized through the end of 2028. The new program replaces the previous buyback authorization. Constellium intends to use some repurchased shares to settle employee equity obligations, aiming to limit future dilution for shareholders. Constellium, trading at $24.61, has laid out a fresh $300 million buyback plan that directly addresses dilution, which many shareholders watch closely. The stock has...

Orchestra BioMed Holdings (OBIO) just posted a sharp step up in activity for FY 2025, with fourth quarter revenue at US$30.9 million and basic EPS of US$0.10, compared with a full year where trailing twelve month revenue sat at US$33.5 million and EPS on that basis was a loss of US$1.11. The company has seen revenue move from quarterly levels below US$1 million through most of the year to the current US$30.9 million print, while quarterly basic EPS shifted from losses between US$0.49 and...

If you have been wondering whether Universal Display's current share price reflects its true worth, you are not alone. This article aims to unpack that question clearly. The stock last closed at US$94.07, and returns of a 3.1% decline over 7 days, a 28.8% decline over 30 days, and a 22.8% decline year to date, as well as a 36.6% decline over 1 year, a 31.9% decline over 3 years, and a 57.2% decline over 5 years, may have reset expectations and risk perceptions for many investors. Recent news...

Northwest Bancshares (NasdaqGS:NWBI) President and CEO Louis J. Torchio recently acquired additional company shares, increasing his personal stake. The insider purchase took place around the time the bank reported strong fourth quarter financial results. The quarter featured earnings and revenue that were ahead of prior expectations, alongside the insider buying activity. Northwest Bancshares is a regional financial institution focused on community banking services, including deposits,...

USA Compression Partners (NYSE:USAC) has agreed to acquire J-W Power, expanding its contract compression fleet and specialty manufacturing capabilities. The deal is positioned around asset repricing opportunities and deeper participation in compression equipment manufacturing. Management is framing the combination as a way to serve rising demand tied to LNG infrastructure and power needs from AI focused data centers. Industry capacity remains tight, with longer lead times for new compression...

AC Immune (NasdaqGM:ACIU) just posted third quarter FY 2025 revenue of CHF 0.9 million and a basic EPS loss of CHF 0.16, with quarterly net income excluding extra items at a loss of CHF 15.9 million. Over recent periods the company has seen revenue move between CHF 0.7 million and CHF 25.5 million per quarter, while EPS has ranged from a loss of around CHF 0.23 per share to a modest profit of CHF 0.06 per share, which underscores how sensitive results can be to revenue timing. For investors,...

Here Group (NasdaqGM:HERE) has just reported Q2 2026 results that mark a sharp reset in the top line, with revenue at C¥127.1 million and a basic EPS loss of C¥0.49, while the trailing 12 month figures still reflect a net profit margin of 12.3%. Over recent quarters the company has seen revenue move from C¥1,000.1 million in Q4 2024 to C¥810.4 million in Q1 2025, then to C¥726.6 million in Q2 2025, C¥570.7 million in Q3 2025 and C¥617.8 million in Q4 2025. Over the same period, basic EPS...

Eastman Kodak (KODK) just closed out FY 2025 with Q4 revenue of US$290 million and a basic EPS loss of US$0.85, capping a year in which trailing 12 month revenue was US$1.07 billion and EPS loss reached US$1.47. Over recent quarters, revenue has moved from US$247 million in Q1 2025 to US$290 million in Q4, while quarterly basic EPS ranged from a loss of US$0.12 to a wider loss of US$0.85 as margins came under pressure. With the stock trading at US$6.97, this set of results focuses attention...

Angel Studios FY 2025 Results: Revenue Growth Meets Persistent Losses Angel Studios (ANGX) has reported new figures for FY 2025, with third quarter revenue at about US$76.5 million and a basic EPS loss of US$0.25. Over the trailing twelve months, revenue stands at roughly US$242.7 million and the basic EPS loss at US$3.54. The company’s quarterly revenue has moved from US$20.1 million in Q3 2024 to US$31.0 million in Q4 2024, then to US$47.4 million in Q1 2025, US$87.6 million in Q2 2025 and...

Lennar (LEN) has kicked off its Q1 2026 reporting cycle with investors watching how its recent revenue and EPS trends set the tone for the year, after posting Q4 2025 revenue of US$9.4b and basic EPS of US$1.93, alongside Q3 2025 revenue of US$8.8b and EPS of US$2.29. Over the last few quarters, the company has seen revenue move from US$9.9b and EPS of US$4.06 in Q4 2024 to US$7.6b and EPS of US$1.96 in Q1 2025. This gives investors a clear run of numbers to weigh against a trailing net...

Transcontinental Realty Investors (TCI) has wrapped up FY 2025 with fourth quarter revenue of US$12.1 million and basic EPS of US$0.96, alongside trailing 12 month EPS of US$1.60 on revenue of US$49.1 million. This lines up with a 135.5% earnings uplift and a net profit margin of 28.1%. Over recent quarters, revenue has been relatively steady in a US$11.7 million to US$12.8 million range, while basic EPS has moved from US$0.01 in Q4 2024 to US$0.96 in Q4 2025. This has taken place against a...

American Public Education (APEI) closed FY 2025 with Q4 revenue of US$158.3 million and basic EPS of US$0.70, alongside trailing twelve month revenue of US$648.9 million and EPS of US$1.40, setting a clear earnings season marker for investors. The company reported a decline in quarterly revenue from US$164.1 million in Q4 2024 to US$158.3 million in Q4 2025, while basic EPS increased from US$0.65 to US$0.70 over the same period, and those figures now sit against trailing twelve month net...

VEON (NasdaqGS:VEON) has just reported new figures for FY 2025, with Q3 revenue of US$1.1 billion, a basic EPS loss of US$2, and a net income loss of US$131 million, setting the tone for how the year is shaping up. The company’s quarterly revenue has moved from US$998 million in Q4 2024 to US$1.1 billion in Q3 2025. Over the same period, basic EPS shifted from about US$1.14 in Q4 2024 to US$8.5 in Q2 2025 and then to a loss of US$2 in Q3 2025, leaving investors focused on how the reported...

Illumina (NasdaqGS:ILMN) and Nashville Biosciences have expanded the Alliance for Genomic Discovery by adding Regeneron Genetics Center as a member. The alliance is launching a new multiomic dataset initiative that includes 312,000 whole genomes and 50,000 paired whole genome and proteomic samples. The effort involves major pharmaceutical firms, including GSK, Amgen and now Regeneron, to support large scale drug discovery and clinical research across diverse diseases. For investors watching...

American Realty Investors (ARL) just wrapped up FY 2025 with Q4 revenue of US$13.0 million and basic EPS of US$0.61, alongside trailing twelve month EPS of US$0.97 and net income of US$15.7 million. Over recent quarters, revenue has ranged from US$11.8 million to US$13.0 million while quarterly EPS has moved between roughly US$0.01 and US$0.61, and the latest period also sits within a year that included a one off gain of US$19.7 million. For investors, that mix of higher earnings levels, a...